Y555 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â °¨±â¾à | Anti-common-cold drugs causing adverse effects in therapeutic use |
|
Y556 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº Ç×õ½ÄÁ¦ | Antiasthmatics, NEC causing adverse effects in therapeutic use |
|
Y556 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¾Æ¹Ì³ëÇʸ° | Aminophylline causing adverse effects in therapeutic use |
|
Y556 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ìºÎŸ¸ô | Salbutamol causing adverse effects in therapeutic use |
|
Y556 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ƽ¿ÀºÎ·Î¹Î | Theobromine causing adverse effects in therapeutic use |
|
Y556 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Å׿ÀÇʸ° | Theophylline causing adverse effects in therapeutic use |
|
Y557 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÀÏÂ÷ÀûÀ¸·Î È£Èí°èÅë¿¡ ÀÛ¿ëÇÏ´Â ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ Á¦Á¦ | Other and unspecified agents primarily acting on the respiratory system causing adverse effects in therapeutic use |
|
Y56 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÀÏÂ÷ÀûÀ¸·Î ÇǺΠ¹× Á¡¸·¿¡ ÀÛ¿ëÇÏ´Â ¾àÁ¦¿Í ¾È°úÀû, À̺ñÀÎÈÄ°úÀû ¹× Ä¡°úÀû Á¦Á¦ | Agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs causing adverse effects in therapeutic use |
|
Y56 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±¹¼ÒÀûÀ¸·Î »ç¿ëµÈ ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀ̵å | Glucocorticoids, topically used causing adverse effects in therapeutic use |
|
Y560 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ±¹¼Ò Ç×Áø±ÕÁ¦, Ç×°¨¿°Á¦ ¹× Ç׿°ÁõÁ¦ | Local antifungal, anti-infective and anti-inflammatory drugs, NEC causing adverse effects in therapeutic use |
|
Y561 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Ç×°¡·Á¿òÁ¦ | Antipruritics causing adverse effects in therapeutic use |
|
Y562 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±¹¼Ò¼ö·ÅÁ¦ ¹× ±¹¼Ò¼¼Á¤Á¦ | Local astringents and local detergents causing adverse effects in therapeutic use |
|
Y563 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¿ÏÈÁ¦, Á¡È°Á¦ ¹× º¸È£Á¦ | Emollients, demulcents and protectants causing adverse effects in therapeutic use |
|
Y564 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â °¢Áú¿ëÇØÁ¦, °¢ÁúÇü¼ºÁ¦ ¹× ±âŸ ¸ð¹ßÄ¡·á ¾à¹° ¹× Á¦Á¦ | Keratolytics, keratoplastic and other hair treatment drugs and preparations causing adverse effects in therapeutic use |
|
Y565 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¾È°ú ¾à¹° ¹× Á¦Á¦ | Ophthalmological drugs and preparations causing adverse effects in therapeutic use |
|
Y566 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â À̺ñÀÎÈÄ°ú ¾à¹° ¹× Á¦Á¦ | Otorhinolaryngological drugs and preparations causing adverse effects in therapeutic use |
|
Y567 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±¹¼ÒÀûÀ¸·Î ¹Ù¸£´Â Ä¡°ú ¾àÁ¦ | Dental durgs, topically applied causing adverse effects in therapeutic use |
|
Y568 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ±¹¼Ò¼º Á¦Á¦ | Other topical agents causing adverse effects in therapeutic use |
|
Y568 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ìÁ¤ÀÚÁ¦ | Spermicides causing adverse effects in therapeutic use |
|
Y569 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â »ó¼¼ºÒ¸íÀÇ ±¹¼Ò Á¦Á¦ | Topical agent, unspecified causing adverse effects in therapeutic use |
|